Cargando…
Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
The intestinal epithelial receptor Guanylyl Cyclase C (GUCY2C) is a tumor-associated cell surface antigen expressed across gastrointestinal malignancies that can serve as an efficacious target for colorectal cancer immunotherapy. Here, we describe a yeast surface-display approach combined with an or...
Autores principales: | Rampuria, Pragya, Mosyak, Lidia, Root, Adam R., Svenson, Kristine, Agostino, Michael J., LaVallie, Edward R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435522/ https://www.ncbi.nlm.nih.gov/pubmed/37591971 http://dx.doi.org/10.1038/s41598-023-40467-0 |
Ejemplares similares
-
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors
por: Root, Adam R., et al.
Publicado: (2021) -
GUCY2C at the intersection of obesity and colorectal cancer
por: Waldman, Scott A, et al.
Publicado: (2013) -
Intestinal neuropod cell GUCY2C regulates visceral pain
por: Barton, Joshua R., et al.
Publicado: (2023) -
Hormone suppression silencing GUCY2C is required for colorectal cancer
por: Waldman, Scott A
Publicado: (2015) -
Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
por: von Volkmann, Hilde L., et al.
Publicado: (2017)